Paul Pridgeon, founder of the Pridgeon Design Group, crafted this medical device logo for Werfen—a global leader in developing, manufacturing, and distributing point-of-care and laboratory instruments, reagents, and data management solutions for hospitals worldwide.
GEM Hemochron 100 Whole Blood Hemostasis system delivers quality results for monitoring and guiding unfractionated heparin therapy during cardiovascular procedures, including cardiac ablation and extracorporeal life support. Leveraging Hemochron technology, the system helps improve workflow and quality of care. Simple cartridge-based technology reduces maintenance and facilities training for greater efficiency.
Werfen is a growing, family-owned, innovative company founded in 1966 in Barcelona, Spain. They are a worldwide leader in specialized diagnostics in the areas of Hemostasis, Acute Care Diagnostics, Transfusion, Autoimmunity, and Transplant. They operate directly in 30 countries, and in more than 100 territories through distributors. Their headquarters are in Barcelona, Spain and their Technology Centers are located in the United States and Europe. Worldwide sales in 2024 were almost € 2.2 billion and their workforce is 7,000 strong.
